Cessatech AS (XSAT:CESSA) Total Stockholders Equity: kr6.39 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CESSA Cessatech AS XSAT:CESSA
19 GF Score
Price kr9.10
! 2 Warning Signs
View Full Analysis

What is Cessatech AS Total Stockholders Equity?

Cessatech AS XSAT:CESSA -5.21% 19 Total Stockholders Equity is kr6.39 Mil as of Jun. 2026. GuruFocus rates XSAT:CESSA with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Cessatech AS's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr6.39 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cessatech AS's Book Value per Share for the quarter that ended in Jun. 2026 was kr0.34. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cessatech AS's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.00.


Cessatech AS  (XSAT:CESSA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cessatech AS's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cessatech AS's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cessatech AS Total Stockholders Equity Related Terms


Cessatech AS Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cessatech AS's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cessatech AS Total Stockholders Equity Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 26.24 23.86 -1.92 8.27 12.16

Cessatech AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.95 13.15 12.16 9.06 6.39
XSAT:CESSA
19GF Score
Cessatech AS XSAT:CESSA
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of kr6.39 Mil mean?
Cessatech AS (XSAT:CESSA) has a Total Stockholders Equity of kr6.39 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cessatech AS and its competitors.
Is Cessatech AS's Total Stockholders Equity too high?
Cessatech AS's current Total Stockholders Equity is kr6.39 Mil. Overall, Cessatech AS has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Cessatech AS's Total Stockholders Equity compare to VRTX and REGN?
Cessatech AS's Total Stockholders Equity of kr6.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cessatech AS and its competitors. Cessatech AS's current Total Stockholders Equity is kr6.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cessatech AS stock overvalued right now?
Cessatech AS (XSAT:CESSA) has a current Total Stockholders Equity of kr6.39 Mil. The current Total Stockholders Equity is kr6.39 Mil. Cessatech AS's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Cessatech AS (XSAT:CESSA), the current Total Stockholders Equity is kr6.39 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cessatech AS Business Description

Other Exchanges 8GN:Germany
Address Strandvejen 60, Hellerup, DNK, DK- 2900
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. The company is advancing a pipeline comprising three assets, all addressing an unmet medical need in the treatment of children. The main candidate, CT001, a fixed-dose nasal spray for treating acute pain in children, is in the pre-launch phase in the U.S. and the EU. CT002, a non-invasive intranasal sedation for children undergoing medical procedures (e.g., MRI scans), has an approved PIP in the EU. CT003, a topical anaesthetic, is currently in pre-clinical development.
19GF Score

Get the complete analysis for XSAT:CESSA

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.10
Price